naltrexone has been researched along with oxadiazoles in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceballos-Reyes, G; Granados-Soto, V; Jiménez-Andrade, GY; Reyes-García, G; Sereno, G; Vidal-Cantú, GC | 1 |
Afshari, K; Daneshpazhooh, M; Dehpour, AR; Foroutan, A; Haddadi, NS; Ostadhadi, S; Shakiba, S | 1 |
Fukumura, K; Kubota, R; Ohnishi, S; Wajima, T | 1 |
1 trial(s) available for naltrexone and oxadiazoles
Article | Year |
---|---|
Absorption, distribution, metabolism, and excretion of radiolabeled naldemedine in healthy subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Carbon Radioisotopes; Constipation; Healthy Volunteers; Humans; Inactivation, Metabolic; Intestinal Absorption; Male; Naltrexone; Nausea; Oxadiazoles; Tissue Distribution | 2019 |
2 other study(ies) available for naltrexone and oxadiazoles
Article | Year |
---|---|
Pyritinol reduces nociception and oxidative stress in diabetic rats.
Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Female; Indomethacin; Naltrexone; Oxadiazoles; Oxidative Stress; Pyrithioxin; Quinoxalines; Rats; Rats, Wistar; Streptozocin | 2008 |
Attenuation of serotonin-induced itch by sumatriptan: possible involvement of endogenous opioids.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Humans; Injections, Intradermal; Male; Mice; Naltrexone; Narcotic Antagonists; Opioid Peptides; Oxadiazoles; Piperazines; Pruritus; Quaternary Ammonium Compounds; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Sumatriptan | 2018 |